Articles tagged with Targeted Drug Delivery
A phase III study uses IL13-PE38QQR, a hybrid protein that attaches to specific receptors on tumor cells, to target residual GBM brain tumors. The treatment, convection-enhanced delivery, facilitates infusion of the drug into the brain, bypassing the blood-brain barrier.
Researchers have developed a three-way drug delivery system using vesicles, allowing for the simultaneous release of different materials in a single vehicle. This innovation could minimize toxic side effects and enhance the effectiveness of medications.
Researchers are exploring alternative methods for delivering drugs, including handheld electronic inhalers, dry powder injection and implantable microchips. These innovative systems have the potential to deliver precise doses of medication in a faster and more efficient manner than traditional hypodermic needles.